Autonomix Medical (@AutonomixMed) / X

Autonomix Medical

526 posts

Autonomix Medical

@AutonomixMed

Autonomix is focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. Nasdaq: $AMIX

The Woodlands, TX

autonomix.com

Joined September 2023

Autonomix Medical
@AutonomixMed
Jun 23
Autonomix's standalone neural sensing platform will be built on the same core technology as its lead pancreatic cancer pain program, enabling a capital-efficient expansion into cardiology and targeting the multi-billion-dollar cardiovascular market with a potential Class II
00:00
82
Autonomix Medical
@AutonomixMed
Jun 22
"These preclinical results support what we believe is a fundamental advantage of our platform – to see the nerve, guide the therapy, and confirm the result in real time," said Brad Hauser, CEO of Autonomix. Read more: bit.ly/3SB1dSj $AMIX
00:00
108
Autonomix Medical
@AutonomixMed
Jun 22
Autonomix today announced the development of a proprietary standalone neural sensing platform following preclinical results showing evidence of the ability to identify renal neural activity and detect real-time changes in neural activity following intervention. Read more:
00:00
34
Autonomix Medical
@AutonomixMed
Jun 10
In a new CEO Corner segment, CEO Brad Hauser highlights the Company’s growing scientific and clinical recognition as its differentiated nerve-sensing and transvascular denervation platform gains traction across leading global medical conferences. bit.ly/40qP3vL $AMIX
00:00
61
Autonomix Medical
@AutonomixMed
Jun 10
Autonomix today announced the release of its latest CEO Corner segment featuring President and Chief Executive Officer, Brad Hauser. Watch here: bit.ly/40qP3vL $AMIX
00:00
53
Autonomix Medical
@AutonomixMed
Jun 4
In the latest Virtual Investor “What This Means”, Dr. Toufic Kachaamy discusses the significance of Autonomix’s Society of Surgical Oncology podium presentation and the clinical relevance of the data in a new Virtual Investor “What This Means.” bit.ly/42Vr0q2 $AMIX
00:00
77
Autonomix Medical reposted
Virtual Investor Co.
@InvestorVirtual
Jun 4
Dr. Toufic Kachaamy, Chief of Medicine at City of Hope Phoenix, joins a #WhatThisMeans segment to discuss the clinical significance of $AMIX’s data presented at the SSO Annual Meeting and its selection for a podium presentation. 🔗: vimeo.com/1198379906/a5e… #MedTech
1.5K
Autonomix Medical
@AutonomixMed
Jun 4
In a new Virtual Investor “What This Means” segment, Dr. Toufic Kachaamy discusses Autonomix’s differentiated approach to visceral cancer pain, pancreatic cancer feasibility data, and broader potential of its peripheral nervous system platform. Watch: bit.ly/42Vr0q2
00:00
43
Autonomix Medical
@AutonomixMed
May 19
Brad Hauser, Chief Executive Officer of Autonomix Medical, comments on the issuance of a new U.S. patent that further strengthens the Company’s intellectual property foundation for next-generation neuromodulation technologies: bit.ly/4dCdoW0 $AMIX
00:00
210
Autonomix Medical
@AutonomixMed
May 19
Autonomix's recently issued patent provides IP protection for technology that unlocks minimally invasive transvascular access to nerve targets and tissues through and beyond the lumen wall. Read more about Autonomix's growing global IP portfolio: bit.ly/4dCdoW0 $AMIX
00:00
199
Autonomix Medical
@AutonomixMed
May 19
Autonomix today announced the @USPTO has issued U.S. Patent No. 12,544,131 (the “131 patent”), titled “Systems, Methods, and Devices for Monitoring and Treatment of Tissues Within And/Or Through a Lumen Wall.” Read more: bit.ly/4dCdoW0 $AMIX
00:00
168
Autonomix Medical
@AutonomixMed
May 18
“These abstract acceptances at #EuroPCR underscore the expanding interest in precision-guided, transvascular approaches to peripheral nerve targeting,” said Brad Hauser, Chief Executive Officer of Autonomix. Read more: bit.ly/3RLO7kI $AMIX
00:00
243
Autonomix Medical
@AutonomixMed
May 18
Autonomix announced two abstracts highlighting our innovative transvascular nerve-targeting platform technology have been accepted for presentation at #EuroPCR 2026, the world-leading course in interventional cardiovascular medicine, May 19–22, 2026. bit.ly/3RLO7kI $AMIX
00:00
208